Two-stage phase II study of imatinib mesylate in subjects with refractory or relapsing neuroblastoma.

Saved in:
Bibliographic Details
Title: Two-stage phase II study of imatinib mesylate in subjects with refractory or relapsing neuroblastoma.
Authors: Calafiore, L.1, Amoroso, L.1, Della Casa Alberighi, O.2, Luksch, R.3, Zanazzo, G.4, Castellano, A.5, Podda, M.3, Dominici, C.6, Haupt, R.7, Corrias, M. V.8, Garaventa, A.1
Source: Annals of Oncology. May2013, Vol. 24 Issue 5, p1406-1413. 8p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1093/annonc/mds648